The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Drinking water arsenic in Utah: A cohort mortality study.
Open accessAbstract
The association of drinking water arsenic and mortality outcome was investigated in a cohort of residents from Millard County, Utah. Median drinking water arsenic concentrations for selected study towns ranged from 14 to 166 ppb and were from public and private samples collected and analyzed under the auspices of the State of Utah Department of Environmental Quality, Division of Drinking Water. Cohort members were assembled using historical documents of the Church of Jesus Christ of Latter-day Saints. Standard mortality ratios (SMRs) were calculated. Using residence history and median drinking water arsenic concentration, a matrix for cumulative arsenic exposure was created. Without regard to specific exposure levels, statistically significant findings include increased mortality from hypertensive heart disease [SMR = 2.20; 95% confidence interval (CI), 1.36-3.36], nephritis and nephrosis (SMR = 1.72; CI, 1.13-2.50), and prostate cancer (SMR = 1.45; CI, 1.07-1. 91) among cohort males. Among cohort females, statistically significant increased mortality was found for hypertensive heart disease (SMR = 1.73; CI, 1.11-2.58) and for the category of all other heart disease, which includes pulmonary heart disease, pericarditis, and other diseases of the pericardium (SMR = 1.43; CI, 1.11-1.80). SMR analysis by low, medium, and high arsenic exposure groups hinted at a dose relationship for prostate cancer. Although the SMRs by exposure category were elevated for hypertensive heart disease for both males and females, the increases were not sequential from low to high groups. Because the relationship between health effects and exposure to drinking water arsenic is not well established in U.S. populations, further evaluation of effects in low-exposure populations is warranted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer Incidence in Five Continents
(1970) · Springer eBooks · doi:10.1007/978-3-642-85851-2 · Cited by 8,501
Statistical Methods in Cancer Research
Breslow, N. E. (1980) · Cited by 7,332
No adjustments are needed for multiple comparisons.
Rothman, K. J. (1990) · Epidemiology · doi:10.1097/00001648-199001000-00010 · Cited by 5,965
The Pathogenesis of Atherosclerosis — An Update
Ross, R. (1986) · New England Journal of Medicine · doi:10.1056/nejm198602203140806 · Cited by 4,877
Statistical Methods in Cancer Research. Volume II – The Design and Analysis of Cohort Studies
Juul, S. (1989) · Scandinavian Journal of Social Medicine · doi:10.1177/140349488901700214 · Cited by 3,592
Prevalence of Skin Cancer in an Endemic Area of Chronic Arsenicism in Taiwan 2
(1968) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/40.3.453 · Cited by 787
Chen, C.-J., Chen, C., Wu, M.-M., & Kuo, T.-L. (1992) · British Journal of Cancer · doi:10.1038/bjc.1992.380 · Cited by 773
Smith, A. H., Goycolea, M., Haque, R., & Biggs, M. L. (1998) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009507 · Cited by 758
Effects and dose-response relationships of skin cancer and blackfoot disease with arsenic
Tseng, W.-P. (1977) · Environmental Health Perspectives · doi:10.1289/ehp.7719109 · Cited by 757
WU, M.-M., KUO, T.-L., HWANG, Y.-H., & CHEN, C.-J. (1989) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a115439 · Cited by 648
Chen, C., Chuang, Y.-C., Lin, T., & Wu, H.-Y. (1985) · PubMed · Cited by 623
Chatterjee, A., Das, D., Mandal, B. K., Chowdhury, T. R., Samanta, G., & Chakraborti, D. (1995) · The Analyst · doi:10.1039/an9952000643 · Cited by 490
Increased Prevalence of Hypertension and Long-term Arsenic Exposure
Chen, C.-J., Hsueh, Y.-M., Lai, M.-S., Shyu, M.-P., Chen, S.-Y., Wu, M.-M., Kuo, T.-L., & Tai, T.-Y. (1995) · Hypertension · doi:10.1161/01.hyp.25.1.53 · Cited by 450
Chiou, H., Hsueh, Y. M., Liaw, K. F., Horng, S. F., Chiang, M., Pu, Y., Lin, J. S. N., Huang, C. H., & Chen, C. (1995) · PubMed · Cited by 445
Chen, C., & Wang, C. (1990) · PubMed · Cited by 427
Bladder Cancer Mortality Associated with Arsenic in Drinking Water in Argentina
Hopenhayn-Rich, C., Biggs, M. L., Fuchs, A., Bergoglio, R., Tello, E. E., Nicolli, H., & Smith, A. H. (1996) · Epidemiology · doi:10.1097/00001648-199603000-00003 · Cited by 390
Ingested Inorganic Arsenic and Prevalence of Diabetes Mellitus
Lai, M.-S., Hsueh, Y.-M., Chen, C.-J., Shyu, M.-P., Chen, S.-Y., Kuo, T.-L., Wu, M.-M., & Tai, T.-Y. (1994) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a117031 · Cited by 354
Diabetes Mellitus Associated with Arsenic Exposure in Bangladesh
Rahman, M., Tondel, M., Ahmad, S. A., & Axelson, O. (1998) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009624 · Cited by 350
Dose-Response Relationship Between Ischemic Heart Disease Mortality and Long-term Arsenic Exposure
Chen, C.-J., Chiou, H.-Y., Chiang, M.-H., Lin, L.-J., & Tai, T.-Y. (1996) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.16.4.504 · Cited by 316
Chen, C. J., Chuang, Y. C., You, S. L., Lin, T. M., & Wu, H. Y. (1986) · British Journal of Cancer · doi:10.1038/bjc.1986.65 · Cited by 306
Chiou, H.-Y., Huang, W.-I., Su, C.-L., Chang, S.-F., Hsu, Y.-H., & Chen, C.-J. (1997) · Stroke · doi:10.1161/01.str.28.9.1717 · Cited by 294
Chen, C. J., Wu, M. M., Lee, S. S., Wang, J. D., Cheng, S. H., & Wu, H. Y. (1988) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.8.5.452 · Cited by 280
Borgoño, J. M., Vicent, P., Venturino, H., & Infante, A. (1977) · Environmental Health Perspectives · doi:10.1289/ehp.19-1637404 · Cited by 253
An investigation of the familial aspects of carcinoma of the prostate
Woolf, C. M. (1960) · Cancer · doi:10.1002/1097-0142(196007/08)13:4<739::aid-cncr2820130414>3.0.co;2-e · Cited by 242
Case-Control Study of Bladder Cancer and Arsenic in Drinking Water
Bates, M. N., Smith, A. H., & Cantor, K. P. (1995) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a117467 · Cited by 232
Quality of Community Drinking Water and the Occurrence of Spontaneous Abortion
Aschengrau, A., Zierler, S., & Cohen, A. (1989) · Archives of Environmental Health: An International Journal · doi:10.1080/00039896.1989.9935895 · Cited by 202
Fixation, transformation, and mobilization of arsenic in sediments
Brannon, J. M., & Patrick, W. H. (1987) · Environmental Science & Technology · doi:10.1021/es00159a005 · Cited by 194
Engel, R. R., & Smith, A. H. (1994) · Archives of Environmental Health: An International Journal · doi:10.1080/00039896.1994.9954996 · Cited by 188
HARRINGTON, J. M., MIDDAUGH, J. P., MORSE, D. L., & HOUSWORTH, J. (1978) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112635 · Cited by 172
Warner, M. L., Moore, L. E., Smith, M. T., Kalman, D. A., Fanning, E., & Smith, A. H. (1994) · PubMed · Cited by 157
Cancer Incidence in Mormons and Non-Mormons in Utah, 1966–1970
Lyon, J. L., Klauber, M. R., Gardner, J. W., & Smart, C. R. (1976) · New England Journal of Medicine · doi:10.1056/nejm197601152940303 · Cited by 150
Chemical Quality of Maternal Drinking Water and Congenital Heart Disease
Zierler, S., Theodore, M., COHEN, A., et al. (1988) · International Journal of Epidemiology · doi:10.1093/ije/17.3.589 · Cited by 127
Cancer Incidence in Mormons and Non-Mormons in Utah, 1966-1970
Lyon, J. L., Klauber, M. R., Gardner, J. W., & Smart, C. R. (1983) · CA A Cancer Journal for Clinicians · doi:10.3322/canjclin.33.5.309 · Cited by 119
Skin cancer and water arsenic in lane county, Oregon
Morton, W. E., Starr, G. F., Pohl, D., Stoner, J., Wagner, S. L., & Weswig, P. H. (1976) · Cancer · Cited by 103
Shared risk factors for cancer and atherosclerosis—a review of the epidemiological evidence
Hansen, E. S. (1990) · Mutation Research/Reviews in Genetic Toxicology · doi:10.1016/0165-1110(90)90004-u · Cited by 90
The metabolism of arsenite and arsenate by the rat
Lerman, S., & Clarkson, T. W. (1983) · Fundamental and Applied Toxicology · doi:10.1016/s0272-0590(83)80145-6 · Cited by 79
Concentration and chemical species of arsenic in human tissue
Yamauchi, H., & Yamamura, Y. (1983) · Bulletin of Environmental Contamination and Toxicology · doi:10.1007/bf01608697 · Cited by 48
Cancer incidence among Mormons and non-Mormons in Utah (United States) 1971–85
Lyon, J. L., Gardner, K., & Gress, R. E. (1994) · Cancer Causes & Control · doi:10.1007/bf01830261 · Cited by 45
Health response by questionnaire in arsenic-exposed populations
Valentine, J. L., He, S.-Y., Reisbord, L. S., & Lachenbruch, P. A. (1992) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(92)90097-7 · Cited by 21
Guo, H., & Valberg, P. A. (1997) · Environmental Geochemistry and Health · doi:10.1023/a:1018458723577 · Cited by 14
Cited by
Endocrine-Disrupting Chemicals: An Endocrine Society Scientific Statement
Diamanti-Kandarakis, E., Bourguignon, J.-P., Giudice, L. C., Hauser, R., Prins, G. S., Soto, A. M., Zoeller, R. T., & Gore, A. C. (2009) · Endocrine Reviews · doi:10.1210/er.2009-0002 · Cited by 4,585
Arsenic round the world: a review
Mandal, B. K., & Suzuki, K. T. (2002) · Talanta · doi:10.1016/s0039-9140(02)00268-0 · Cited by 3,543
Arsenic Exposure and Toxicology: A Historical Perspective
Hughes, M. F., Beck, B. D., Chen, Y., Lewis, A. S., & Thomas, D. J. (2011) · Toxicological Sciences · doi:10.1093/toxsci/kfr184 · Cited by 1,312
Acute and chronic arsenic toxicity
Ratnaike, R. N. (2003) · Postgraduate Medical Journal · doi:10.1136/pmj.79.933.391 · Cited by 1,175
Toxicological profile for arsenic
United States, A. F. T. S. A. D. R. S. R. C. (2007) · doi:10.15620/cdc:11481 · Cited by 1,175
Metadata
- Authors
- Lewis, D. R., Southwick, J. W., Ouellet-Hellstrom, R., Rench, J., & Calderon, R. L.
- Venue
- Environmental Health Perspectives
- Publisher
- American Chemical Society (ACS)
- Published
- 1999-05
- Volume
- 107
- Issue
- 5
- Pages
- 359-365
- ISSN
- 0091-6765 (ISSN-L)
- 1552-9924
- OpenAlex
- W2048068440
- Cited by
- 372
- References
- 40
- FWCI
- 16.73
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.